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Abstract
Introduction: Intracranial vascular complications are an important complication of acute bacterial meningitis.
Ischemic stroke in meningitis is reported as a result of vasculitis, vasospasm, endocarditis or intraarterial thrombosis.
The aim of the study was to identify the value of measuring cerebral blood flow velocity (CBFv) on transracranial
doppler (TCD) in the identification of patients at risk for meningitis-associated stroke.
Methods: We retrospectively studied patients with acute bacterial meningitis who were treated in our university
hospital from 2000 to 2009. Data were analyzed with the main focus on the incidence of an increase of CBFv on
TCD, defined as peak systolic values above 150 cm/s, and the development of stroke.
Results: In total, 114 patients with acute bacterial meningitis were treated, 94 of them received routine TCD
studies during their hospital stay. 41/94 patients had elevated CBFv values. This increase was associated with an
increased risk of stroke (odds ratio (95% confidence intervall) = 9.15 (1.96-42.67); p < 0.001) and unfavorable
outcome (Glasgow Outcome Score < 4; odds ratio (95% confidence intervall) = 2.93 (1.23-6.98); p = 0.018). 11/32
(34.4%) patients with an increase of CBFv who received nimodipine and 2/9 (22.2%) patients with an increase of
CBFv who did not receive nimodipine developed stroke (p = 0.69).
Conclusions: In summary, TCD was found to be a valuable bedside test to detect arterial alterations in patients
with bacterial meningitis. These patients have an increased risk of stroke.
Introduction
The development of cerebrovascular alterations is an
important intracranial complication in acute bacterial
meningitis and is associated with poor outcome [1].
Arterial cerebrovascular complications are reported to
occur in approximately one-fifth of patients [2]. Using
digital subtraction angiography (DSA), arterial narrow-
ing is the predominant finding in patients with arterial
complications, involving all vessel sizes [1]. The underly-
ing reason for narrowing of the cerebral arteries during
bacterial meningitis is still a matter of debate. Autopsy
and animal model studies indicate severe inflammation
of the vessel walls (vasculitis) as a key etiology [3,4].
Furthermore, patients in whom histopathological corre-
lates in terms of inflammation were not found at the
sites of arterial narrowing have been reported [5,6]. This
suggests vasospasm as a second important etiology.
Also, ischemic stroke can occur as the result of
endocarditis and septic emboli. Recently, the develop-
ment of arterial cerebral infarctions was reported to
occur up to weeks after initial recovery from pneumo-
coccal meningitis and an association with adjunctive
steroid therapy was suggested [7]. Autopsy studies in
such patients showed intraarterial clotting but no signs
of vasculitis and intraarterial thrombosis was suggested
to be a fourth reason for the development of stroke [7].
Furthermore, diffuse cerebral vascular coagulation was
proposed as the main etiology for stroke in another
autopsy series on 15 patients who died from pneumo-
coccal meningitis [8]. Unfortunately, in vivo vascular
imaging was not performed in these two studies. Given
the fact that arterial complications in bacterial meningi-
tis are associated with a poor prognosis, the question
how arterial alterations can be detected early and in a
feasible way during bacterial meningitis arises. Here, we
retrospectively studied the data of 114 patients with
acute bacterial meningitis who were treated at our uni-
versity hospital from 2000 to 2009 with the scope on an
increase of cerebral blood flow velocity (CBFv) on
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stroke and an adverse outcome.
Materials and methods
Patients
Data of all patients with acute bacterial meningitis who
were treated at the Department of Neurology at Klini-
kum Grosshadern, the teaching hospital of the Ludwig-
Maximilians University Munich, Germany, from 2000
until 2009 were analyzed. Bacterial meningitis was diag-
nosed through (i) isolation of bacteria from the cere-
brospinal fluid (CSF) and/or (ii) the presence of clinical
symptoms (fever, headache, impaired consciousness,
and/or neck stiffness) in combination with typical altera-
tions of the CSF. Typical CSF findings were defined as a
mainly granulocytic CSF white blood cell count (CSF-
WBC) of more than 1,000 cells/μl, an increase of CSF
protein of more than 100 mg/dl, and a CSF/serum glu-
cose ratio less than 0.3.
Detection of arterial narrowing
The presence of vascular alterations was assessed by
TCD of the anterior cerebral artery (ACA), middle cere-
bral artery (MCA), internal cerebral artery (ICA), poster-
ior cerebral artery (PCA), and the basilar artery (BA).
Systolic CBFv greater than 150 cm/s were considered
increased [9].
Stroke and outcome in patients with arterial narrowing
Arterial vascular alterations and the incidence of cere-
bral ischemia were evaluated using magnetic resonance
imaging (MRI) and computed tomography (CT) [10].
Only lesions with a configuration typical of ischemic
stroke (corresponding to an arterial vessel territory or
watershade infarctions) were diagnosed as cerebral
ischemia. On MRI, ischemic stroke was diagnosed when
lesions were found to be hyperintense on diffusion-
weighted imaging and T2-weighted imaging. On CT
scan, ischemic lesions appeared hypodense. Effects of
arterial vascular alterations on outcome measured with
the Glasgow Outcome Scale (GOS; 1 = death, 2 = vege-
tative state, 3 = severe disabilities, 4 = moderate disabil-
ities, 5 = no/mild disabilities) were assessed.
Statistical analysis
Systat 9 (Chicago, IL, USA) was used for statistical ana-
lysis. The Wilcoxon-Mann-Whitney test and Chi
squared test as well as the Fisher’se x a c tt e s tw a su s e d
for analysis of demographic and clinical characteristics
of patients with and without vascular alterations. Odds
ratios and 95% confidence intervals were calculated. P <
0.05 was considered significant. The study is in compli-
ance with the Declaration of Helsinki on Ethical Princi-
ples for Medical Research involving Human Subjects.
Due to the completely retrospective nature of the study
without the possibility to identify patients from the
anonymous collected data, the ethics committee of the
University of Munich gave ethical approval and waved
the need for informed consent of the patients.
Results
Patients
From 2000 to 2009, 114 adult patients with bacterial
meningitis were treated in our hospital. A causative
pathogen was identified in 95 cases (83%). The most
common pathogens were Streptococcus pneumoniae (48
of 95 patients; 50.5%) followed by Staphylococcus aureus
( 1 0o f9 5p a t i e n t s ;1 0 . 5 % )a n dNeisseria meningitidis (9
of 95 patients; 9.4%). Overall mortality was 15%.
Vascular complications
In 94 of 114 patients, data on TCD studies were avail-
able. High systolic CBFv greater than 150 cm/s were
detected in 41 of 94 (43%) patients (systolic CBFv ±
standard deviation = 222 ± 45 cm/s). In 63% of these
patients, CBFv was increased in vessels of both the ante-
rior and posterior circulation. In 35% of patients, the
increase of CBFv was noted only in the anterior circula-
tion, and in 2% only in the posterior circulation. An
increase of CBFv on TCD was detected in 45% of
patients within two days after treatment was begun. In
21% of patients, changes were detected more than seven
days after initiation of therapy. In one patient, changes
were observed until 51 days after the start of therapy.
However, this particular patient suffered from subarach-
noid hemorrhage as an alternative reason for an increase
of CBFv. In 6 of 13 patients who received arterial MRI,
vascular alterations that were found on TCD were con-
firmed by MR angiography. Vascular alterations were
also confirmed in one of five patients who received CT
angiography and in two of two patients who received
DSA. One of these patients also received MR and CT
angiography, revealing no vascular alterations; the other
one received MR angiography and DSA, both showing
arterial narrowing.
Factors associated with an elevation of CBFv
The occurrence of vascular alterations on TCD was
associated with a lower Glasgow Coma Score (GCS) on
admission (Table 1). TCD alterations were not asso-
ciated with certain causative pathogens (Table 1). CSF
WBC, CSF albumin content, CSF glucose, and CSF/
serum glucose on admission were not different in
patients with and without increased CBFv on TCD.
Data on the application of corticosteroids was available
in 82 patients. Patients who showed increased CBFv on
TCD had more often received corticosteroids as adjunc-
tive therapy on admission to the hospital (Table 1). The
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initial therapy presented with a lower GCS on admission
(P = 0.002).
Increased CBFv and outcome
Increased CBFv was associated with an odds ratio of
9.15 (95% confidence interval: 1.96 to 42.67) for the
development of ischemic stroke. Ischemic stroke was
found in 14 of 41 patients with TCD alterations (two of
them were also suffering from endocarditis as a possible
source of embolism), whereas only 2 of 51 patients with-
out TCD alterations suffered from stroke (Table 2). In 3
of the 14 patients with increased CBFv, stroke was not
restricted to the vessel territory in which increased
CBFv were detected (one of them suffering from endo-
carditis). In the group of patients with stroke but no
TCD alterations, one suffered from atrial fibrillation as a
possible etiology of cerebral ischemia. In the other
patient, a possible etiology was not found. If stroke
occurred in more than one arterial territory, an increase
of CBFv in all vessels and/or endocarditis was detected
(Table 3). An increase of CBFv was associated with
unfavorable outcome (GOS 1, 2, or 3; Table 2). 32
patients with an increase of CBFv received therapy with
nimodipine (intravenously or orally), 11 of them (34.4%)
developing stroke (2 of the 11 patients suffering from
endocarditis). Two of nine patients (22.2%) with an
increase of CBFv who did not receive nimodipine
experienced cerebral ischemia (P = 0.69).
Findings on autopsy
In one patient with increased CBFv, corresponding
arterial narrowing on DSA, and cerebral ischemia,
inflammation was seen surrounding middle and small
Table 1 Risk factors for increased sCBF in patients with bacterial meningitis
All patients Increase in CBFv No increase in CBFv Odds ratio
(95% CI)
P value
n =9 4 n = 41 (43.6%) n = 53 (56.4%)
Male/Female 38/56 15/26 23/30 0.75 (0.32-1.73) 0.53
Age in years 56(16-81) 46(18-81) 59(16-81) 0.125
GCS (admission) 11(3-15) 11(3-15) 12(7-15) 0.033
Causative pathogen
Streptococcus pneumoniae 46 23 (56.1%) 23 (43.4%) 1.67 (0.73-3.79) 0.218
Neisseria meningitidis 8 4 (9,7%) 4 (7.5%) 1.05 (0.25-4.52) 0.725
Staphylococcus aureus 6 2 (4.9%) 4 (7.5%) 0.62 (0.11-3.61) 0.693
Haemophilus influenzae 4 1 (2.4%) 3 (5.7%) 0.42 (0.04-4.16) 0.629
Streptococcus intermedius 3 1 (2.4%) 2 (3.7%) 0.69 (0.06-7.89) 1.00
Others* 12 5 (12.2%) 7 (13.2%) 0.91 (0.27-3.12) 1.00
Pathogen not detected 17 8 (19.5%) 9 (17.0%) 1.45 (0.51-4.14) 0.792
CSF findings on admission
CSF cell count (cells/μl) 1600 (7-37800) 986 (7-10667) 2208 (35-37800) 0.374
CSF albumin (mg/dl) 254 (39-4455) 236 (39-1358) 277 (52-4455) 0.677
CSF glucose (mg/dl) 16 (0-175) 12 (0-64) 23 (0-175) 0.256
CSF/serum glucose 0.19 (0.00-0.59) 0.14 (0.00-0.45) 0.21 (0.02-0.59) 0.655
Adjunctive therapy with corticosteroids 34/82 20/36 14/46 2.86 (1.15-7.09) 0.026
(*) Streptococcus mitis, Streptococcus pyogenens, Listeria monocytogenes, Streptococcus agalacticae, Acinetobacter baumanii, Fusobacterium necrophorum, Escherichia
coli. Multiple pathogens were detected in three patients.
(#) In one patient, Gram-positive bacteria were seen on Gram stain but a further differentiation was not successful.
CBFv, cerebral blood flow velocity; CI, confidence interval; CSF, cerebrospinal fluid; GCS, Glasgow Coma Scale.
Table 2 An increase of rCBF is associated with stroke and poor outcome
All patients Increase in CBFv No increase in CBFv Odds Ratio
(95% CI)
P value
Ischemic stroke 16 14 2 9.15 (1.96-42.67) < 0.001
Glasgow Outcome Scale (GOS)* 4 (1-5) 3 (1-5) 4 (1-5) 0.029
GOS 1, 2 or 3 37 22 15 2.93 (1.23-6.98) 0.018
GOS 4 or 5 54 18 36 0.34 (0.14-0.81) 0.018
Time until discharge from ICU (days) 12 (1-112) 15 (3-112) 9 (1-59) 0.096
*Data available for 91 patients.
CBFv, cerebral blood flow velocity; CI, confidence interval.
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reason for the vascular alterations found in vivo.
Autopsy data from other patients were not available
(due to denial of autopsy by relatives).
Discussion
The major findings of our study were that (i) 43.6% of
patients showed vascular alterations on TCD and (ii)
these alterations were seen more often in patients with
Table 3 Characteristics of patients with meningitis and stroke
Age Pathogen GCS GOS TCD Stroke Concomitant
complications
Remarks
Time
point
CBFv Location Time
point
Imaging Location
years 3-
15
1-5 days cm/s days
17 9 S- pneum.7 1 1 0 >
150
Basilar
artery
12 MRI Posterior
circulation
Hydrocephalus,
epileptic seizures,
sepsis
Arterial narrowing on MRA
26 7 S. pneum. 3 1 12 300 All vessels 12 MRI MCA, ACA,
posterior
circulation
Hydrocephalus,
epileptic seizures,
severe sepsis,
subarachnoid
hemorrhage
Arterial narrowing on digital
subtraction angiography
3 27 N/A 5 1 1 >
150
posterior
circulation
1 CT left MCA
and ACA,
posterior
circulation
Severe sepsis
45 6 S. pneum.9 2 5 1 >
150
N/A 51 MRI posterior
circulation
Hydrocephalus Arterial narrowing on MRA
56 2 S. pneum. 7 2 250 All vessels 16 MRI right MCA,
posterior
circulation
Hydrocephalus,
empyema,
paravertebral
abscesses
66 5 S. pneum. 3 2 5 300 All vessels 21 MRI right MCA Hydrocephalus
epileptic seizures,
sepsis
74 3 S. pneum. 9 2 7 180 All vessels 5 MRI left ACA,
left MCA,
posterior
circulation
subarachnoid
hemorrhage
Arterial narrowing on digital
subtraction angiography,
Increased CBFv in TCD
documented for 2 months
84 4 S. pneum. 5 3 0 210 All vessels CT left MCA
(watershade)
Hydrocephalus,
bilateral hypakusis
Arterial narrowing on MRA
94 0 S. pneum. 12 3 9 270 All vessels 17 MRI Posterior
circulation
Hydrocephalus,
cerebritis
10 77 N/A 12 3 23 258 Right and
left MCA,
posterior
circulation
N/A MRI Posterior
circulation
Intracranial
hemorrhage
11 37 Gram-
positive
bacteria*
6 3 25 >
150
All vessels 17 MRI Posterior
circulation
Brain oedema,
sepsis, ARDS, renal
failure
12 64 E. coli 11 3 N/A >
150
All vessels 1 MRI left MCA Endocarditis
13 37 S. pneum. 7 4 1 230 All vessels 18 MRI Right and
left MCA
Hydrocephalus,
Hypakusis
14 42 S.
agalacticae
11 N/A 0 230 Right and
left MCA
1 MRI Left ACA
and MCA
Endocarditis
15 67 S. pneum.7 4 1 0 <
150
All vessels 9 MRI Right and
left ACA
16 76 Pseud.
aeruginosa
940 <
150
All vessels 0 MRI Posterior
circulation,
left MCA
atrial fibrillation
(*) On Gram stain, further differentiation not possible. ACA, anterior cerebral artery; CBFv, cerebral blood flow velocity; E. coli, Escherichia coli; GCS, Glasgow Coma
Scale; GOS, Glasgow Coma Scale; MCA, medial cerebral artery; MRI, magnetic resonance imaging; Pseud., Pseudomonas; S. agalacticae, Streptococcus agalacticae; S.
pneum., Streptococcus pneumonia; TCD, transcranial Doppler.
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greater than 150 cm/s evidenced by TCD were asso-
ciated with (iii) the development of ischemic stroke and
(iv) unfavorable outcome. (v) Treatment of an increase
of CBFv with nimodipine was not associated with a
reduction of stroke.
The current study demonstrates that an increase of
CBFv is common in bacterial meningitis. Here, we
detected an increase of systolic CBFv greater than 150
cm/s in 41 of 94 patients (43.6%) with acute bacterial
meningitis. In earlier smaller case series, similar rates
have been reported: for example, an increase of the
CBFv was found in 23 of 41 patients (51%) with acute
bacterial meningitis [11] and in 27 of 53 (51%) patients
with bacterial meningitis during the first two weeks of
admission [12]. Also, a very high incidence of vascular
alterations was reported in a case series of 22 patients
with bacterial meningitis, with markedly increased systo-
lic peak velocities (> 210 cm/s) in seven patients [13].
Taken together with the high incidence of TCD altera-
tions found in the large group of patients of this study,
this demonstrates that cerebrovascular complications are
frequently found in patients with bacterial meningitis.
The high incidence of cerebrovascular complications
f o u n do nT C D ,i nc o m p a r i s o nw i t ht h a tr e p o r t e db y
studies looking at alterations on MR angiography, DSA,
and ischemic stroke in selected patients, is likely to only
be related to the simplicity of using TCD. This also
allowed screening for vascular alterations in critically ill
patients without the necessity for invasive, time consum-
ing, and, sometimes, risky investigations that are often
only performed if focal neurologic signs appear. In addi-
tion, the cost is low. One limitation of TCD is the
necessity to obtain bone cranial windows, which might
be difficult in some patients. However, the use of bed-
side TCD seems to be a helpful and feasible tool for
clinical practice to screen patients with bacterial menin-
gitis for vascular alterations, aiming at the identification
of patients at high risk for ischemic stroke.
Alterations of CBFv on TCD were seen more often in
patients that were severely affected clinically on admis-
sion. This is in line with the previous observations that
a low GCS and a low CSF glucose on admission are risk
factors for intracranial complications and poor outcome
[2,14]. Calculation of odds ratios identified initial
adjunctive corticosteroid treatment to be associated with
the development of arterial complications. One likely
explanation is that corticosteroids were especially given
to patients with severe clinical affection on admission.
Thus, it cannot be concluded from the results of this
study that adjunctive corticosteroids lead to the develop-
ment of arterial narrowing. However, it has to be kept in
mind that case series discussing a possible association of
steroid use and stroke in pneumococcal meningitis have
recently been published [7].
An increase of CBFv greater than 150 cm/s on TCD
was associated with an increased incidence of ischemic
stroke. Nevertheless, negative TCD studies do not rule
out the chance of ischemic stroke: 2 of 53 meningitis
patients without an increase of CBFv on TCD developed
cerebral ischemia (one of them suffering from endocar-
ditis). In the daily routine on our ICU, systolic CBFv
greater than 150 cm/s was considered indicative of vas-
culopathy. Nevertheless, arterial narrowing indicated by
an increase of CBFv was only confirmed by MR angio-
g r a p h yi n6o f1 3p a t i e n t s ,C Ta n g i o g r a p h yi no n eo f
five patients, and DSA in two of two patients. Unfortu-
nately, exact timely correlations with imaging studies,
especially DSA (gold standard) were not possible from
our data. Thus, it remains unclear which threshold of
CBFv on TCD should be considered pathologic in
patients with bacterial meningitis. Nevertheless, here, a
threshold of 150 cm/s helped to identify 14 of 16
patients (87.5%) with stroke.
Vascular alterations occur mainly during the first days
after admission but can be found even later. If altera-
tions were detected on TCD in this study, they were
present more than one week after admission in 21%.
This is in line with the observation that stroke can
occur later after the onset of bacterial meningitis
[1,3,7,15]. As this was a retrospective study without a
predetermined time point of TCD and/or other imaging
evaluation of the patient, the exact onset of vascular
alterations and/or stroke might have been missed.
Nevertheless, the fact that an increase in CBFv was clo-
sely associated with stroke in such a high percentage
even though TCD was performed not on a predeter-
mined timely basis underlines its value in clinical prac-
tice. Altogether, this demonstrates the necessity to
monitor patients early, closely, and long enough in
order to identify patients at risk of stroke early.
What can be done if vascular alterations such as arter-
ial narrowing are detected? An increase of CBFv on
TCD can be the result of narrowing of the arterial
lumen or hyperperfusion. Possible underlying reasons
for narrowing of cerebral arteries in meningitis were
shown to be vasospasm and/or vasculitis, as evidenced
by histopathology in patients who died during acute
bacterial meningitis [1,3]. Clearly, randomized controlled
trials on possible treatment strategies of arterial narrow-
ing in bacterial meningitis are non-existent. Another
disease with prolonged narrowing of cerebral arteries is
subarachnoid hemorrhage (SAH) [16], TCD having
become a valuable tool to identify patients with SAH-
associated vasospasms [17,18]. Such patients with SAH
that develop cerebral vasospasms are often treated with
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perfusion (triple H therapy) in combination with intra-
venous or oral nimodipine [19]. Whether such
therapeutic strategies can be transferred to practice in
bacterial meningitis is unclear at present. Due to the
risk of cerebral bleeding in infections of the central ner-
vous system, extensive hypertension might even be
harmful to the patient. Nimodipine would potentially
also act in the case of meningitis-associated vasospasm
(but not vasculitis) as the underlying etiology for an
increase of CBFv on TCD. Here, therapy with intrave-
nous or oral nimodipine was not of benefit. One could
argue that a possible effect of nimodipine might have
been missed due to the very small number of patients
not receiving nimodipine, but the proportion of patients
with stroke despite nimodipine treatment was high.
Administration of nimodipine is often associated with a
drop of the arterial blood pressure. Keeping in mind
that the cerebral autoregulation can be affected during
bacterial meningitis [20], such a decrease of the blood
pressure could easily affect the cerebral perfusion pres-
sure, potentially being of risk to the patient (especially
in the case of vasculitis of large and small blood vessels).
Combined, nimodipine cannot be recommended for
routine therapy of meningitis-related TCD alterations.
Intraarterial clotting might be another mechanism for
the development of stroke. Thus, anticoagulation with
heparin or antiplatelet strategies could be discussed as
potential treatment strategies. However, given the fact
that intracranial bleeding is a frequent complication in
pneumococcal meningitis, administration of drugs that
interfere with coagulation seem dangerous. In a small
study on the use of heparin which included 15 patients
with bacterial meningitis, outcome not improved in
patients receiving heparin vs. those not receiving
heparin (mortality 57% vs. 25%, respectively) [21]. Thus,
the use of heparin cannot be recommended without
clinical studies. If strategies that aim at the inhibition of
the coagulation cascade or stimulation of fibrinolysis
could be of benefit in bacterial meningitis yet need to
be evaluated in experimental studies.
Due to its retrospective nature, this study has several
limitations. Only 94 of 114 patients with bacterial
meningitis received TCD studies. However, it has to be
noted that the outcome of the remaining 20 patients
w i t h o u tT C Ds t u d i e sw a sw o r s et h a ni nt h eg r o u po f
patients with TCD studies (mortality in patients without
TCD studies = 55% vs. mortality in patients with TCD
studies = 5.3%). The major reason for this selection bias
was that in many of the non-TCD-investigated patients,
clinical problems such as renal failure with the need of
dialysis, airway control, and severe sepsis and extensive
blood pressure management as well as control of intra-
vascular disseminated coagulopathy dominated the
treatment of these patients, giving highest priority to
high urgent directly life saving measures. Thus, the
actual number of patients with an increase of CBFv on
TCD might have been underestimated. Unfortunately,
continuous TCD studies were not available in this
patient series, therefore we cannot comment on the
course of vascular alterations and it is unclear how long
patients with vascular alterations remain at risk for
ischemia. However, the fact that patients with bacterial
meningitis develop stroke even weeks after meningitis
shows that a high level of suspicion for vascular compli-
cations should be sustained even after the acute stage of
the disease is overcome.
Conclusions
In summary, this study demonstrates that vascular
alterations are common in bacterial meningitis. The fact
that the development of vascular alterations is associated
with stroke and unfavorable outcome underlines its
importance for the course of the disease. TCD is shown
to be an easy to perform bedside test, not being asso-
ciated with risks to the patient. Thus, TCD seems an
excellent tool to identify patients at high risk for the
development of stroke and unfavorable outcome.
Clearly, studies on possible treatment strategies of vas-
cular complications in bacterial meningitis are needed.
Key messages
◆ An increase of CBFv on TCD is common in
patients with acute bacterial meningitis.
◆ An increase of CBFv on TCD is associated with
ischemic stroke and poor outcome in acute bacterial
meningitis.
◆ TCD is a very easy and useful investigation to
detect patients at risk for cerebral ischemia in bac-
terial meningitis.
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